Christopher Moxham

Insider Reports History

Entity
Individual
Location
26 Landsdowne Street, Cambridge, MA
Signature
/s/ Peter Thomson, as attorney-in-fact for Christopher Moxham
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Moxham:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Chief Scientific Officer Common Stock 31.1K $103K $3.31 Aug 10, 2021 Direct
Fulcrum Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 72.5K Aug 10, 2021 Direct
Fulcrum Therapeutics, Inc. Chief Scientific Officer Common Stockm 0 $18.00 Aug 10, 2021 Direct

Insider Reports Filed by Christopher Moxham

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FULC Fulcrum Therapeutics, Inc. Aug 10, 2021 6 -$505K 4 Aug 12, 2021 Chief Scientific Officer